期刊文献+

血浆脂联素水平与2型糖尿病及其微血管病变的关系 被引量:5

原文传递
导出
摘要 对2型糖尿病有微血管病变(MV)组35例、无微血管病变(NMV)组68例,健康对照(C)组35例,观测其血浆脂联素水平等。结果:三组血浆脂联素水平分别为5.25±3.90ug/ml、5.56±4.22ug/ml、16.37±3.03ug/ml,DM组与C组间差异P<0.001,但MV组与NMV组之间差异P>0.05;3组中低脂联素血症发生率分别为54.3%、57.4%及0.0%,DM组与C组间差异P<0.01,但MV组与NMV组之间差异P>0.05。在糖尿病患者中,血浆脂联素与收缩压呈负相关(P<0.001)。结论:2型糖尿病患者血浆脂联素水平明显降低,但与有无并发症无明显关系。
出处 《实用糖尿病杂志》 2005年第4期17-18,共2页 Journal of Practical Diabetology
基金 广西卫生厅科技项目(合同号:Z2004095)
  • 相关文献

参考文献6

  • 1American Diabetes Association. Report of the expert committee on th expert committee on the diagnosis and classitication of diabetes mellitus Care 1997;20:1183- 1186.
  • 2Maeda N, Takahashi M, Funahashi T, et al. PPARgamma ligands increase expression and plasma concentration of adiponectin, an adipose-derived protein. Diabetes 2001 ;50(9) :2094 - 2099.
  • 3潘云龙,朱妍,王晓玲,程英英,张真稳,王艳,陈晖.2型糖尿病患者血浆脂联素浓度改变及其与胰岛素抵抗的关系[J].实用临床医药杂志,2004,8(4):19-21. 被引量:21
  • 4谷卫,曾文衡,船桥通.2型糖尿病患者皮下、大网膜脂肪组织脂联素mRNA表达的定量研究[J].中华内分泌代谢杂志,2002,18(5):400-403. 被引量:30
  • 5Daimon M, Yamaguchi H, Oizumi T, et al. Decreased serumlevels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population. Diabetes Care 2003; 26:2015 -2020.
  • 6Marcin A, Andrzej W, Tohru F, et al. Decreased plasma adiponectin concentration in patients with essential hypertension. Am J Hypertension 2003; 16 (1) :72 - 75.

二级参考文献19

  • 1李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2125
  • 2Yoda Murakami M, Taniguchi M, Takahashi K, et al. Chang in expression of GB28/adiponectin in carbon tetrachloride administrated mouse liver.Biochem Biophys Res Commun, 2001, 285: 372.
  • 3Nakano Y, Tobe T, Choi-Miura N H, et al. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma[J]. J Biochem, 1996, 120: 803.
  • 4Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity[J]. Nat Med, 2001, 7: 941.
  • 5Hu E, Liang P, Spiegelman B M. AdipoQ is a novel adipose-specific gene dysregulated in obesity[J]. J Biol Chem. 1996 May 3, 271(18): 10697.
  • 6Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity[J]. Biochem Biophys Res Commun. 1999 Apr 2, 257(1): 79.
  • 7Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients[J]. Arterioscler Thromb Vasc Biol. 2000 Jun, 20(6): 1595.
  • 8Hotta K, Funahashi T, Bodkin N L, et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys[J]. Diabetes, 2001 May, 50(5): 1126.
  • 9Yamamoto Y, Hirose H, Saito I, et al. Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population[J]. Clin Sci (Lond). 2002 Aug, 103(2): 137.
  • 10Yang W S, Jeng C Y, Wu T J, et al. Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients[J]. Diabetes Care. 2002 Feb, 25(2): 376.

共引文献41

同被引文献44

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部